BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16340087)

  • 1. APOE2 and consanguinity: a risky combination for Alzheimer's disease.
    Kaur M; Balgir PP
    J Alzheimers Dis; 2005 Dec; 8(3):293-7. PubMed ID: 16340087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China.
    Sun YP; Zhang B; Miao L; Wang XM; Yu JH; Luo L; Ying L; Xin G; Haliakpaer G; Xia H; Yao H
    Lipids Health Dis; 2015 Apr; 14():25. PubMed ID: 25890021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?
    Fernandez LL; Scheibe RM
    Arq Neuropsiquiatr; 2005 Mar; 63(1):1-6. PubMed ID: 15830056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study.
    Zhou L; Li HY; Wang JH; Deng ZZ; Shan YL; Tan S; Shi YH; Zhang MX; Liu SX; Zhang BJ; Hong MF; Lu ZQ; Huang XM
    Medicine (Baltimore); 2018 Sep; 97(38):e12470. PubMed ID: 30235742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes.
    Mustapic M; Popovic Hadzija M; Pavlovic M; Pavkovic P; Presecki P; Mrazovac D; Mimica N; Korolija M; Pivac N; Muck-Seler D
    Metab Brain Dis; 2012 Dec; 27(4):507-12. PubMed ID: 22580620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.
    Ganguli M; Chandra V; Kamboh MI; Johnston JM; Dodge HH; Thelma BK; Juyal RC; Pandav R; Belle SH; DeKosky ST
    Arch Neurol; 2000 Jun; 57(6):824-30. PubMed ID: 10867779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India.
    Chandak GR; Sridevi MU; Vas CJ; Panikker DM; Singh L
    Hum Biol; 2002 Oct; 74(5):683-93. PubMed ID: 12495082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between obstructive sleep apnea syndrome and apolipoprotein E genetic variants.
    Uyrum E; Balbay O; Annakkaya AN; Gulec Balbay E; Silan F; Arbak P
    Respiration; 2015; 89(3):195-200. PubMed ID: 25613112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.
    Graff-Radford NR; Green RC; Go RC; Hutton ML; Edeki T; Bachman D; Adamson JL; Griffith P; Willis FB; Williams M; Hipps Y; Haines JL; Cupples LA; Farrer LA
    Arch Neurol; 2002 Apr; 59(4):594-600. PubMed ID: 11939894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia.
    Luthra K; Tripathi M; Grover R; Dwivedi M; Kumar A; Dey AB
    Dement Geriatr Cogn Disord; 2004; 17(3):132-5. PubMed ID: 14739533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.
    Seshadri S; Drachman DA; Lippa CF
    Arch Neurol; 1995 Nov; 52(11):1074-9. PubMed ID: 7487559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary.
    Kálmán J; Juhász A; Császár A; Kanka A; Maglóczky E; Bencsik K; Janka Z; Raskó I
    Acta Neurol Scand; 1997 Jan; 95(1):56-9. PubMed ID: 9048987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.